GeriMedRisk
 

GeriMedRisk Geriatric Clinical Pharmacology Rounds


GeriMedRisk offers free monthly webcast accredited educational rounds on topics related to safe prescribing for older adults. For more information please join our mailing list. Registration is required to attend.

 

Upcoming GeriMedRisk Virtual Rounds: 

Click below to Download & Share GeriMedRisk Rounds Flyer (PDF Document)
 

GeriMedRisk Rounds Flyer

 


 

GeriMedRisk November Rounds

Nov. 2, 2021  | 12-1 PM EST
Clinical Pearls in Osteoporosis

 

Click Here to Register

 

Presenter:

 

Dr. Rick Adachi, BSc, MD, FRCP(C)   

 

Dr. Rick Adachi is a Professor of Medicine at the Michael G. DeGroote School of Medicine, McMaster University. He is the Actavis Chair for Better Bone Health in Rheumatology.  Dr. Adachi has been involved in clinical trials and epidemiologic research. He either holds or is a co-investigator in several CIHR funded studies including the 20 year Canadian Multicentre Osteoporosis Study (CaMOS), and a separate study examining pQCT, HRpQCT and pMRI images of bone structure and strength to determine the relationship of bone structure and muscle to fractures in a subset of CaMOS subjects.
 

Dr Adachi has over 590 peer reviewed publications and is a respected leader in bone research in Canada and Internationally. He was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he received the North American Menopause Society award for Innovation in Osteoporosis Research. In 2012, he received the Queen Elizabeth II Diamond Jubilee Medal for his work in osteoporosis and in 2014 he was received the Olof Johnell Science Award that honours an individual who has contributed to the field of osteoporosis in a scientific or policy implementation area worldwide. In 2019 he was awarded the Herbert Fleisch Medal by ESCEO-IOF in recognition of his outstanding and innovative contributions in basic or translational science.

 

Learning Objectives:

This presentation will address the following topic areas:

  1. How do we assess fracture risk? What do we mean by imminent fracture risk?
  2. What are the benefits and risks of osteoporosis treatment?
  3. Drug holidays: When do we stop therapy, if ever?
  4. What do RCT’s of bisphosphonate versus denosumab tell us?
  5. When do you measure BMD? Does change in BMD reflect fracture risk reduction?
  6. What is Romosozumab?

 

Missing Nov. 2nd Rounds?

We will be hosting an additional webinar session that will broadcast a recording of Dr. Rick Adachi's presentation: "Clinical Pearls in Osteoporosis".

 

Replay session: Nov. 17 at 7 pm EST


Click Here to register

Please note: this session will not be interactive

GeriMedRisk- Geriatric Clinical Pharmacology Rounds is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada. 

 

Post Rounds:

Complete your anonymous presenter evaluation here
All registered attendees will receive an attendance certificate.

 

At GeriMedRisk we believe in ensuring that our education and resources are current, scientifically based and reflective of best practices. Due to the risk of material from our rounds presentations being altered or incorrectly interpreted, we are unable to attach or forward the presentation slide deck.